Who Is a Candidate for Spravato Treatment?

Adults with treatment-resistant depression (TRD) who have not found enough relief after trying at least two different oral antidepressants are typically who qualifies. Our team in Surprise, AZ, answers that question through a comprehensive psychiatric evaluation – not a one-size-all checklist. If persistent symptoms remain despite previous treatments, understanding who is a candidate for Spravato treatment is the first step toward a new path to mental wellness.

Understanding Spravato: What It Is and How It Works

Spravato is the brand name for esketamine, a prescription nasal spray that works on the NMDA receptor – a different pathway than most oral antidepressants that typically focus on serotonin, norepinephrine, or dopamine. Our team offers Spravato as part of a coordinated plan that often includes ongoing medication management.

• It is not a first-line option for mild, short-term low mood

• It cannot be taken at home; each session occurs at our comfortable, private, certified medical office in Surprise, AZ

• Our team monitors your progress and safety throughout every visit

Primary Conditions Treated with Spravato

Spravato is FDA-approved for specific and serious depressive disorders. It is not a first-line treatment but a specialized option for those with a documented history of unsuccessful medication trials.

Treatment-Resistant Depression (TRD)

The primary use of Spravato is for adults with treatment-resistant depression. TRD is not a separate diagnosis but a term for Major Depressive Disorder (MDD) that has failed to respond adequately to at least two different oral antidepressant treatments of sufficient dose and duration.

If you have lived with depression for months or years and still feel little change, you may be in this group.

Other Qualifying Mental Health Conditions

Spravato is also approved for depressive symptoms in adults with MDD who are experiencing acute suicidal ideation or behavior, offering rapid relief in crisis as part of a comprehensive care plan. You may still be evaluated if you also live with anxiety, trauma-related symptoms, or other concerns; those conditions do not automatically qualify or disqualify you.

• Co-occurring issues reviewed include anxiety, insomnia, and bipolar-related symptoms

• What matters is whether severe depression is a central problem and whether Spravato can be used safely alongside your other care

• A thorough evaluation is necessary to determine if this use is appropriate for your circumstances

Eligibility Criteria for Spravato Treatment

To ensure patient safety and treatment effectiveness, strict criteria must be met before starting Spravato. This process is managed carefully by our team.

Medical Diagnosis and Assessment

Candidacy starts with a documented depressive disorder and a history of limited benefit from oral antidepressants. The first visit is a 60-minute psychiatric evaluation with our dual board-certified provider, who assesses your mental and physical health history, previous treatments, and current symptoms to confirm a diagnosis of Major Depressive Disorder.

• Bring a photo ID and relevant medical history, including a list of medicines you have already tried

• Care is by appointment only; there is no walk-in option

• Local patients can be seen in our Surprise office

• Some evaluation work can be done by telehealth, but Spravato treatment itself is in person because monitoring is required

Required Medical Criteria

To be considered for Spravato, a patient generally must:

• Be at least 18 years old (Spravato is considered for adults with severe, hard-to-treat depression)

• Have a confirmed diagnosis of Major Depressive Disorder

• Have a documented history of trying at least two oral antidepressants without significant improvement

• Be willing to continue taking a daily oral antidepressant as prescribed

• Be able to follow a structured treatment plan and share a full health history

Our team looks at both psychiatric and general health factors before moving forward. Two people with the same diagnosis can receive different recommendations; the decision is based on your record and your safety, not on a sales pitch.

• Attend all scheduled in-office appointments for administration and monitoring

• Stay for required observation after each session

• Arrange transportation home after every session; you will not be able to drive or operate machinery for the rest of the day

• Continue agreed-upon oral antidepressant care

If you cannot commit to that structure, you may not be a good fit even if your diagnosis matches.

Who May Not Qualify for Spravato?

Spravato is not suitable for everyone; a comprehensive screening is essential to identify contraindications and other disqualifying factors.

Disqualifying Factors and Contraindications

Individuals with the following conditions are generally not candidates for Spravato:

• A history of aneurysmal vascular disease or arteriovenous malformations

• A history of bleeding in the brain (intracerebral hemorrhage)

• Allergies or hypersensitivity to esketamine or ketamine

• Uncontrolled high blood pressure, a history of psychosis, or severe liver impairment (these require careful consideration and may prevent candidacy)

• Depression that has not been fully assessed, or another condition that better explains your symptoms

• Inability to stay for monitoring, arrange transportation, or follow the treatment schedule

• Active medical issues that need attention first, which can delay or prevent treatment

If Spravato is not appropriate, other options still exist, including evaluation and medication management tailored to your diagnosis.

Important Considerations Before Starting Spravato

Spravato is a significant commitment that requires active participation; it is not a standalone cure but one component of a broader medication management plan.

Patient Responsibilities and Expectations

Patients must be prepared to follow the prescribed treatment schedule and stay in ongoing communication with their provider.

• Follow a schedule that is more intensive at the beginning and gradually becomes less frequent

• Arrive on time, report side effects or mood changes, and take agreed-upon medicines

• Be honest about substances, sleep, and stressors

• Results vary; some people notice change sooner than they did on pills alone, while others need more time and close follow-up

Safety and Monitoring Requirements

Your safety is our priority. Every Spravato treatment is administered in our clinic; after you use the nasal spray, you will rest in a comfortable setting for at least two hours while our team monitors your blood pressure and observes for side effects, such as sedation or dissociation.

• On-site monitoring is a mandatory part of every treatment session

• You will need a plan to get home and should not drive or operate machinery for the rest of the day – until the next day after a restful night

Next Steps: Scheduling an Evaluation for Spravato Treatment

If you have been living with depression that has not responded to traditional medications, you don’t have to lose hope. Call Alpha Health and Wellness at 480-996-6373 to schedule your comprehensive Spravato evaluation with Stephanie Dockins.

• Office: 15027 West Bell Road, Surprise, AZ

• Bring your photo ID and relevant medical history

• Be ready to discuss past antidepressants in detail

From there, you will leave with a clear yes, no, or “not yet,” plus a plan that matches your needs.

Conclusion

So, who is a candidate for Spravato treatment? Adults with treatment-resistant depression who have not found enough relief from at least two oral antidepressants, who can follow in-office administration and monitoring rules, and who pass a full clinical review. Our team makes that decision through a 60-minute psychiatric evaluation that confirms the diagnosis, reviews treatment history, and assesses for medical contraindications. If that description sounds like you, schedule an assessment and get a direct answer based on your history – not on guesswork.